PTC Therapeutics, Inc. - Common Stock (PTCT) — AI analysis & news
PTC Therapeutics, Inc. - Common Stock (PTCT) stock: 7 recent news items, slightly negative aggregate sentiment, AI analysis and market context on BestAIBroker.
Current sentiment read
Across the last 7 indexed PTCT stories, aggregate finance-aware sentiment is slightly negative (-0.20 on a -1 to +1 scale).
Latest PTCT news
- PTC Therapeutics director sells $149,036 in shares By Investing.com - Investing.com Australia · Investing.com Australia
- Officer Mark Elliott Boulding proposes selling 192 shares of PTC Therapeutics (Nasdaq: PTCT). - Stock Titan · Stock Titan
- A $27.9K sale of 435 shares is proposed by PTC Therapeutics (PTCT) officer Mark Boulding. - Stock Titan · Stock Titan
- Officer Mark Boulding proposes selling 1,638 shares of PTC Therapeutics (PTCT). - Stock Titan · Stock Titan
- A director proposes selling $782K in option-exercised PTC Therapeutics (PTCT) shares. - Stock Titan · Stock Titan
- PTC Therapeutics director Schmertzler sells $1.35m shares By Investing.com - Investing.com Australia · Investing.com Australia
- PTC Therapeutics director Schmertzler sells $1.35m shares By Investing.com - Investing.com UK · Investing.com UK
FAQ
What is the current sentiment for PTCT stock?
Aggregate finance-aware sentiment across the last 7 indexed PTCT news stories is slightly negative (-0.20 on a -1 to +1 scale).